HAN Lina, LI Yangyang, BAI Xiaomin. Predictive value of bronchial diastolic response test in adult patients with chronic cough suspected as cough variant asthma[J]. Journal of Clinical Medicine in Practice, 2024, 28(9): 95-98. DOI: 10.7619/jcmp.20232522
Citation: HAN Lina, LI Yangyang, BAI Xiaomin. Predictive value of bronchial diastolic response test in adult patients with chronic cough suspected as cough variant asthma[J]. Journal of Clinical Medicine in Practice, 2024, 28(9): 95-98. DOI: 10.7619/jcmp.20232522

Predictive value of bronchial diastolic response test in adult patients with chronic cough suspected as cough variant asthma

More Information
  • Received Date: August 07, 2023
  • Revised Date: October 22, 2023
  • Available Online: May 14, 2024
  • Objective 

    To explore the value of bronchial diastolic response (BDR) test in predicting the cough variant asthma (CVA) in patients with chronic cough or negative result of BDR test.

    Methods 

    A total of 140 patients with chronic cough and negative result of BDR test were selected and treated with inhaled corticosteroids (ICS) and long-acting β2-agonists for 4 weeks, and their lung functions were detected before and after treatment. Receiver operating characteristic (ROC) curve was used to evaluate the predictive values of the forced expiratory volume in the first second as a percentage of predicted value (FEV1 %), exhaled nitric oxide (FeNO), forced expiratory flow at 25 % to 75 %(FEF25 % to 75 %)and forced expiratory flow rate in 25 % to 75 % (FEF %25 % to 75 %) alone or their combined diagnosis.

    Results 

    After treatment, there were 98 cases diagnosed as negative for CVA and 42 cases diagnosed as positive for CVA. In combination of evaluation indexes, the top three combinations for CVA diagnosis were FEF %25 % to 75 %+△FEV1 %, FEF25 % to 75 % +FeNO, and △FEV1 +△FEV1 %. Venn diagram of the combined prediction showed that there was an overlap in CVA positive diagnostic patients with FeNO ≥ 41.50×10-9 mol/L, △FEV1 % ≥ 5.90 %, and FEF %25 % to 75 % ≤ 61.99 %.

    Conclusion 

    After treatment, patient's showing FeNO ≥ 41.50×10-9 mol/L, △FEV1 % ≥ 5.90 % and FEF %25 % to 75 % ≤ 61.99 % can be used to predict CVA and the response to anti-asthma treatment.

  • [1]
    赖克方. 慢性咳嗽[M]. 2版. 北京: 人民卫生出版社, 2019: 232-236.
    [2]
    LAI K F, CHEN R C, LIN J T, et al. A prospective, multicenter survey on causes of chronic cough in China[J]. Chest, 2013, 143(3): 613-620. doi: 10.1378/chest.12-0441
    [3]
    ZHONG N S, LIN J T, ZHENG J P, et al. Uncontrolled asthma and its risk factors in adult Chinese asthma patients[J]. Ther Adv Respir Dis, 2016, 10(6): 507-517. doi: 10.1177/1753465816663978
    [4]
    中华医学会呼吸病学分会哮喘学组. 支气管哮喘防治指南(2020年版)[J]. 中华结核和呼吸杂志, 2020, 43(12): 1023-1048. doi: 10.3760/cma.j.cn112147-20200618-00721
    [5]
    焦风伟, 侯安纳, 张黎明. 行气道激发试验检查哮喘及非哮喘患者临床分析[J]. 临床肺科杂志, 2022, 27(10): 1509-1513. doi: 10.3969/j.issn.1009-6663.2022.10.012
    [6]
    冯连彩. COPD和哮喘患者支气管舒张实验用力肺活量和呼气容积的变化[J]. 临床肺科杂志, 2012, 17(4): 626-627. doi: 10.3969/j.issn.1009-6663.2012.04.020
    [7]
    朱丽涛, 牟艳. 支气管激发试验和舒张试验在哮喘患者中的应用价值[J]. 海南医学, 2017, 28(6): 907-909. doi: 10.3969/j.issn.1003-6350.2017.06.016
    [8]
    焦蕊, 庞立健, 吕晓东. 基于网络药理学探讨三拗汤治疗咳嗽变异型哮喘的作用机制[J]. 中华全科医学, 2021, 19(7): 1218-1223. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY202107039.htm
    [9]
    谢仁炜, 王朝昕, 李云霞, 等. 区域医疗中心咳嗽患者临床特征及就诊流向的大数据挖掘分析[J]. 中华全科医学, 2022, 20(12): 2143-2146. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY202212037.htm
    [10]
    席寅, 赖克方, 陈如冲, 等. 咳嗽变异性哮喘的临床特征及其与典型哮喘的关系[J]. 中华哮喘杂志: 电子版, 2011, 5(3): 150-155. doi: 10.3969/j.issn.1674-3911.2011.03.001
    [11]
    谭伟, 杨贵丽, 黄招兰. 从全科医学的视角解读中国《咳嗽基层诊疗指南(2018年)》[J]. 中国全科医学, 2019, 22(33): 4035-4040. doi: 10.12114/j.issn.1007-9572.2019.00.502
    [12]
    于成盼, 赵云, 王婷. 咳嗽变异性哮喘患者血清LDH水平与气道炎症指标的相关性及其在预后评估中的价值[J]. 检验医学与临床, 2022, 19(12): 1671-1674. doi: 10.3969/j.issn.1672-9455.2022.12.023
    [13]
    闫利霞. 咳嗽变异性哮喘患儿血清25羟基维生素D3、免疫球蛋白E、血清淀粉样蛋白A水平与预后的相关性[J]. 中国临床医生杂志, 2020, 48(9): 1102-1104. doi: 10.3969/j.issn.2095-8552.2020.09.034
    [14]
    侯俊荣. 布地奈德联和孟鲁司特钠治疗咳嗽变异性哮喘对肺功能指标与免疫球蛋白E和肿瘤坏死因子-α的影响[J]. 中国临床医生杂志, 2019, 47(5): 535-538. doi: 10.3969/j.issn.2095-8552.2019.05.011
    [15]
    FUSSBROICH D, COLAS R A, EICKMEIER O, et al. A combination of LCPUFA ameliorates airway inflammation in asthmatic mice by promoting pro-resolving effects and reducing adverse effects of EPA[J]. Mucosal Immunol, 2020, 13(3): 481-492. doi: 10.1038/s41385-019-0245-2
    [16]
    陈婷婷, 易桂生. 咳嗽变异性哮喘病理机制及造模方法的研究进展[J]. 实验动物科学, 2021, 38(2): 74-78. doi: 10.3969/j.issn.1006-6179.2021.02.014
    [17]
    PRAKASH Y S, HALAYKO A J, GOSENS R, et al. An official American thoracic society research statement: current challenges facing research and therapeutic advances in airway remodeling[J]. Am J Respir Crit Care Med, 2017, 195(2): e4-e19. doi: 10.1164/rccm.201611-2248ST
    [18]
    刘亚林, 谷峰. 孟鲁司特钠联合氯雷他定对咳嗽变异性哮喘患儿血清和诱导痰炎性介质的影响[J]. 检验医学与临床, 2019, 16(8): 1053-1056. doi: 10.3969/j.issn.1672-9455.2019.08.013
    [19]
    《慢性阻塞性肺疾病诊治指南(2021年修订版)》诊断要点[J]. 实用心脑肺血管病杂志, 2021, 29(6): 134-134.
    [20]
    李新玲, 朱颀峰, 孙爽, 等. 支气管哮喘患者血清MBL、IgE及FeNO的临床价值[J]. 中国老年学杂志, 2022, 42(7): 1620-1623. doi: 10.3969/j.issn.1005-9202.2022.07.026
    [21]
    别柏林, 李安琪, 楚荷莹. FeNO联合血清SDF-1水平对支气管哮喘患者气道高反应的预测价值[J]. 临床肺科杂志, 2021, 26(10): 1506-1510. doi: 10.3969/j.issn.1009-6663.2021.10.011
    [22]
    康恒, 李迅, 文华, 等. COPD患者外周血淋巴细胞计数及血清CRP PCT变化与疾病严重程度的关系[J]. 河北医学, 2023, 29(8): 1287-1292. doi: 10.3969/j.issn.1006-6233.2023.08.011
  • Related Articles

    [1]ZHANG Qiong, LUO Qilin, WANG Kai. Application values of serum procalcitonin, anti-thrombin Ⅲ, D-dimer and four items of coagulation test in early diagnosis of pediatric sepsis[J]. Journal of Clinical Medicine in Practice, 2024, 28(21): 43-47. DOI: 10.7619/jcmp.20242011
    [2]LI Dan, LIU Wei, XIAO Mengyu, WEI Shengjie, DOU Liurui, LI Mengli, NIU Xiaona, NIU Junwei, BAI Yanliang, SUN Kai. Value of D-dimer to immunoglobulin A ratio in evaluating renal impairment in acute phase in Henoch-Schönlein purpura children complicated with gastrointestinal involvement at initial diagnosis[J]. Journal of Clinical Medicine in Practice, 2022, 26(15): 120-124. DOI: 10.7619/jcmp.20220524
    [3]JIANG Wanting, LI Lingmin, AI Hong, JI Wenchen. Significance of ultrasound examination combined with D-dimer in diagnosis of lower extremity venous thrombosis in patients with spinal cord injury[J]. Journal of Clinical Medicine in Practice, 2021, 25(23): 95-98. DOI: 10.7619/jcmp.20212701
    [4]GUO Jian, TANG Jin, ZHU Liang, QIAN Fenghua, ZHAO Lei, QIAN Yiming. Study on relationships between traditional Chinese medicine syndromes and oxygenation index, lactic acid, D-dimer in patients with severe pneumonia[J]. Journal of Clinical Medicine in Practice, 2021, 25(1): 81-84. DOI: 10.7619/jcmp.20200734
    [5]PENG Hao, LI Deyou, DENG Min, XIAO Chen, RONG Jianguo. Value of critical illness score combined with serum D-dimer and procalcitonin in the evaluation of infection condition in children[J]. Journal of Clinical Medicine in Practice, 2020, 24(2): 48-51. DOI: 10.7619/jcmp.202002014
    [6]SUI Chenyan, HU Lingling, WANG Yinming. Influence of Danshen Ligustrazine Injection combinedwith argatroban on levels of D-dimer and serum inflammatory cytokines in patients with acute cerebral infarction[J]. Journal of Clinical Medicine in Practice, 2019, 23(11): 14-16, 19. DOI: 10.7619/jcmp.201911004
    [7]WU Hongli, TIAN Ruixue, YE Qing, SONG Yujia. Expressions of brain natriuretic peptide, fibrinogen,hypersensitive C-reactive protein, D-Dimer and arterial blood gas analysis in acute exacerbation of chronic obstructive pulmonary disease patients complicated with pulmonary hypertension[J]. Journal of Clinical Medicine in Practice, 2018, (3): 31-33,37. DOI: 10.7619/jcmp.201803008
    [8]YUAN Na, WANG Lei. Impact of prothrombin fragment 1 + 2 and D-Dimer on peripherally inserted central catheter associated thrombosis in cancer patients[J]. Journal of Clinical Medicine in Practice, 2017, (19): 24-26,30. DOI: 10.7619/jcmp.201719007
    [9]YANG Yi, LU Xiaoyan, WU Shengbin. Correlation between serum CRP, D-dimer and disease severity and pulmonary function of elderly patients with COPD[J]. Journal of Clinical Medicine in Practice, 2015, (23): 28-30. DOI: 10.7619/jcmp.201523009
    [10]ZHOU Qing, WEN Bing. Correlation between arterial blood gas analysis and serum D-dimer, fibrinogen and homocysteine in patients with COPD[J]. Journal of Clinical Medicine in Practice, 2015, (1): 26-28. DOI: 10.7619/jcmp.201501008
  • Cited by

    Periodical cited type(25)

    1. 吴婧,刘星初. 芬太尼复合罗哌卡因行双侧TAPB镇痛对急诊剖宫产术后母婴安全 寒战及泌乳的影响. 中国妇幼保健. 2025(04): 626-630 .
    2. 项巧鸯,胡壮文,陈剑. 术前不同剂量罗哌卡因腹横肌平面阻滞对腹腔镜卵巢癌根治术患者苏醒质量 认知功能及镇痛效果的影响. 中国妇幼保健. 2024(01): 176-179 .
    3. 武庆涛,徐凯利,张轩宇. 右美托咪定应用剂量对剖宫产产妇术后疼痛及康复的影响. 临床医学工程. 2024(01): 27-28 .
    4. 汪伟,程勤耘,杜伏杨,程典萍. 剖宫产术后地塞米松、右美托咪定复合罗哌卡因行腹横肌平面阻滞镇痛效果. 中国计划生育学杂志. 2024(07): 1513-1518 .
    5. 覃思雨,舒斌,段光友,黄河,但伶. 腹横肌平面阻滞效果影响因素的研究进展. 局解手术学杂志. 2023(04): 363-367 .
    6. 魏丽青,王永强,程旭东,胡建英,朱秀清. 盐酸纳布啡对足月剖宫产产妇疼痛评分清醒时间及不良反应的影响. 中国妇幼保健. 2023(14): 2553-2558 .
    7. 韩萍,张延娇. 超声引导腹横肌平面阻滞联合右美托咪定用于剖宫产术后镇痛的效果及对母婴免疫功能的影响. 海南医学. 2023(16): 2344-2348 .
    8. 方丽林. 艾司氯胺酮在剖宫产术后镇痛中的应用效果及对产妇术后康复质量的影响. 中国医学创新. 2023(28): 137-141 .
    9. 刘丹,沈佳佳. 中药贴敷联合健康教育对剖宫产术后患者睡眠质量和泌乳功能的影响. 中国妇幼保健. 2022(02): 342-345 .
    10. 潘先凤,张海萍,周龑,陈旭,谢晓海,赵光耀,曾薇. 罗哌卡因复合右美托咪定腹横肌平面阻滞在剖宫产患者中的应用价值. 成都医学院学报. 2022(02): 197-200 .
    11. 赵建益,刘宇,单晓山,胡孙浩. 腹横筋膜平面阻滞联合剖宫产术后静脉自控镇痛对产妇泌乳功能及性功能的影响. 中国性科学. 2022(06): 99-102 .
    12. 孙颖,刘庄,刘晓利,赵倩倩,阮芳. 右美托咪定和芬太尼分别联合罗哌卡因对腹横肌平面阻滞剖宫产产妇的影响. 实用临床医药杂志. 2022(14): 109-113 . 本站查看
    13. 贾佳,于悦,聂洋洋,文爱平. 超声引导下腰方肌阻滞与腹横肌阻滞对剖宫产术后镇痛 血流动力学及氧化应激水平的影响. 中国妇幼保健. 2022(21): 4076-4079 .
    14. 王伟明. 超声引导髂腹下/髂腹股沟神经阻滞对剖宫产术后镇痛效果的影响. 中国医药导报. 2021(01): 119-122 .
    15. 汪俊. 不同浓度右美托咪定联合罗哌卡因应用于剖宫产术后腹横肌平面阻滞镇痛中的效果比较. 临床合理用药杂志. 2021(14): 103-105 .
    16. 吕小艳. 地塞米松对罗哌卡因用于剖宫产术后TAP阻滞镇痛效果的影响分析. 黑龙江中医药. 2021(01): 117-118 .
    17. 彭德亮. 腹横筋膜阻滞联合喉罩全麻对行剖宫产术产妇SBP、HR、BIS的影响. 医学理论与实践. 2021(11): 1913-1915 .
    18. 林琳. 超声引导下双侧腹横肌平面阻滞对剖宫产产妇术后疼痛度及PCIA用药量的影响. 哈尔滨医药. 2021(04): 74-75 .
    19. 王平,沈刚,徐德芬. 不同剂量右美托咪定腹横肌平面阻滞对剖宫产术后产妇镇痛效果及泌乳功能的影响. 海南医学. 2021(18): 2365-2368 .
    20. 王萍,陈瑞琼,卢凤仙. 剖宫产术后产妇入复苏室的观察与护理. 中国社区医师. 2021(27): 159-160 .
    21. 刘忠,缪凡,赵鸿雁,刘娟,路峰,张承民. 右美托咪定复合罗哌卡因对剖宫产产妇血流动力学和应激反应的影响. 武警后勤学院学报(医学版). 2021(11): 32-33+36 .
    22. 么娜,蔺杰,贾玉刚. TAPB联合剖宫产术后应用舒芬太尼静脉自控镇痛对产妇应激反应和舒适度的影响. 中国性科学. 2020(08): 55-58 .
    23. 林锐波,周慧芬,高星,周良军,袁鹏飞. B超引导下腹横肌平面阻滞于剖宫产术后静脉自控镇痛的应用. 中国社区医师. 2020(26): 39-41 .
    24. 王亚丽,贾树山. 超声引导下行腹横肌平面阻滞对二次剖宫产产妇术后疼痛及泌乳素水平的影响. 现代医学与健康研究电子杂志. 2020(16): 4-7 .
    25. 张长满,王世民,赵雪峰. 右美托咪定复合罗哌卡因对剖宫产产妇血流动力学、应激反应指标的影响. 中国妇幼保健. 2019(18): 4172-4175 .

    Other cited types(1)

Catalog

    Article views (95) PDF downloads (7) Cited by(26)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return